Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498931
Title: The assessment of cardiac biomarkers in rat models of cardiotoxicity
Author: Brady, Sally Marie
ISNI:       0000 0004 2670 5308
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2008
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Cardiotoxicity is an adverse effect of many drugs and chemicals. However, the assessment of toxic myocardial injury in preclinical animal studies for drug safety evaluation has not been optimised. At present, cardiac injury is generally assessed using serum enzymes and these changes are correlated with histopathological lesions in the heart. Nevertheless, it has recently been suggested that the assessment of cardiac injury using serum enzymes as biomarkers lacks sensitivity and it has therefore been proposed that new markers should be identified and validated; a proposed new serum marker is cardiac troponin I (cTnI). The aim of the present investigations was to develop models of cardiotoxicity in the Hanover Wistar rat using isoproterenol (ISO), allylamine (AA) and erucic acid (EA), to assess the usefulness of serum cTnI in comparison with the traditional markers of myocardial injury. Single dose studies with ISO and AA resulted in myocardial degeneration/necrosis, and vasculopathy was also present in the case of AA. These experiments demonstrated that serum cTnI was a sensitive and specific biomarker of acute cardiomyocyte injury. Administration of EA, by gavage or in the diet, induced myocardial lipidosis and necrosis. Serum levels of cTnI were generally elevated in association with myocardial necrosis, but not with lipidosis. It is concluded that cTnI is a sensitive and organ-specific marker of cardiotoxicity in the rat, but further validation studies are required with a wider range of cardiotoxic agents.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.498931  DOI: Not available
Share: